ArticlePloS one2017

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.

S De Groot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.